scorecardresearch
Add as a preferred source on Google
Friday, October 24, 2025
TopicIndian drugs

Topic: Indian drugs

36 drugs to treat cancer, rare diseases exempted from basic customs duty in Union Budget 2025

Lakhs of patients are likely to benefit from this move as some of these drugs were exorbitant to procure.

India has a substandard, fake drugs problem. Lack of recall law, scrutiny is making matters worse

Underlining need for more accountability, experts also stress that govt data does not include fixed dose combination drugs, which account for over 40% of drugs sold in India.

ICMR calls for development of local drugs for rare diseases, offers assistance in clinical research

The medical research body aims to encourage domestic companies to develop cost-effective treatments for rare conditions, such as spinal muscular atrophy, Gaucher disease, among others.

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Under revised good manufacturing practices (GMP) norms, pharma companies will be required to assume onus for quality of drugs to ensure they do not place patients at risk.

Regulatory actions taken against 105 pharma companies, says health minister Mansukh Mandaviya

The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas.

WHO says 20 ‘contaminated’ drugs from Indian & Indonesian makers under scanner

WHO spokesperson says instances of contaminated drugs being found in 6 countries warranted Medical Product Alerts & that it takes reports of substandard medical products seriously.

‘Feeding cough syrup seems like Russian roulette’—new book exposes drug regulation in India

Dinesh S. Thakur and Prashant Reddy tapped into the nitty gritty of drug regulation, cough syrups and medicines in India at the launch of their book ‘Truth Pill’ in Delhi.

How Delhi Police’s war against drugs saved India from becoming another Colombia

In ‘Khaki in Dust Storm’, former DGP Amod K. Kanth revisits the 1980s and 1990s when India witnessed riots, political assassinations & growing culture of drug abuse.

Trump’s ‘Buy American First’ order will actually favour India — drug export body tells govt

Pharmexcil has told Modi govt that Indian generics constitute 10% of the US generic market in value terms & the order may give Indian drugmakers a chance to capture more.

Modi govt plans action against US writer who said Indian drugs are ‘flea-market quality’

In her May 2019 book Bottle of Lies, Katherine Eban accused Indian pharma firms of major lapses such as ‘toxic impurities’ and fudging data on quality control.  

On Camera

In Bihar, BJP is courting upper castes—a clear shift from its 2020 strategy

With two parties led by Dalit leaders now part of NDA, the BJP is hopeful of winning a large number of reserved constituencies.

Boom to bust: Haunted by Ketan Parekh saga, 117-yr-old Calcutta Stock Exchange’s future lies in limbo

CSE, one of India’s oldest bourses, is edging towards a voluntary exit. It could never recover from market manipulation scam that caused a payment crisis at exchange back in 2001. 

From battle of wits and daring air strikes to artillery fury, new details emerge of Operation Sindoor

Fresh details of operation conducted by IAF, Army have come out in gazette notification giving citations of those who were awarded Vir Chakra for their bravery.

CJI, IPS, IAS & Homebound: A wake-up call 75 years in the making

Education, reservations, govt jobs are meant to bring equality and dignity. That we are a long way from that is evident in the shoe thrown at the CJI and the suicide of Haryana IPS officer. The film Homebound has a lesson too.